Patients. Subjects. Participants. The role they play in bringing new drugs to market is vital

That’s why we don’t just help to deliver clinical trials. We help to deliver hope. We develop and deliver patient centric clinical supply chain solutions, and flexible clinical supply strategies, that keep people at the heart of our mission.

That’s why we Supply With Care…

Our clinical supply chain solutions

Participating in a clinical trial can be a lifeline for patients. It can also be a burden; impacting on patients’ time and finances. When combined with other common barriers to access, significant recruitment and retention challenges can materialise.

Almac to Patient

Decentralised clinical trial models are helping to overcome these challenges and Almac to Patient drug distribution is making at home clinical studies possible: removing patient burden by expertly delivering drugs, to people at home, in places all over the world.

Find out more
Almac to Patient

Managed Access Programmes

Similarly, for patients who have benefitted from IMP during a trial, our Managed Access Programmes make it simpler and more cost-effective for sponsors to provide post-trial access to unlicenced medication.

Find out more
Managed Access Programmes

Almac Adapt

And when time is of the essence, when patients are awaiting IMP and every second counts, Almac Adapt – our Just in Time Manufacturing solution – delivers rapid access, reduces waste, and effectively mitigates the risk of product shortages that could leave patients without vital medication.

Find out more
Almac Adapt

Pharmacy Services

Harnessed as part of a direct to patient distribution model and our Pharmacy Services can drive further value. With a team of highly trained pharmacy professionals, we’re ready to support you to maximise the potential of your decentralised clinical trial.

Find out more
Pharmacy Services

Meet our Team

Find out more about our global Business Development Team and Senior Management

Find out more
This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies